These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19027794)

  • 21. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis.
    Matsuba-Kitamura S; Yoshimoto T; Yasuda K; Futatsugi-Yumikura S; Taki Y; Muto T; Ikeda T; Mimura O; Nakanishi K
    Int Immunol; 2010 Jun; 22(6):479-89. PubMed ID: 20501612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Mittler RS; Yagita H; Ueno H
    J Immunol; 2005 Oct; 175(8):4897-903. PubMed ID: 16210591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis.
    Ishida W; Fukuda K; Kajisako M; Sumi T; Matsuda H; Yagita H; Fukushima A
    Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):289-95. PubMed ID: 21779950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
    Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
    Fukushima A; Ozaki A; Jian Z; Ishida W; Fukata K; Ueno H; Liu FT
    Curr Eye Res; 2005 Apr; 30(4):241-8. PubMed ID: 15823916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell Ig and mucin domain-containing protein (Tim)-2 regulates murine allergic conjunctivitis during the effector phase.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
    Immunol Lett; 2007 Jun; 110(2):133-8. PubMed ID: 17532058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis.
    Sumi T; Fukushima A; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
    Immunol Lett; 2007 Jan; 108(1):62-7. PubMed ID: 17109973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.
    Ueta M; Matsuoka T; Narumiya S; Kinoshita S
    J Allergy Clin Immunol; 2009 Feb; 123(2):466-71. PubMed ID: 18996575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Roles of cytokines in the development of severe allergic conjunctival diseases: analyses using animal models].
    Fukushima A
    Nippon Ganka Gakkai Zasshi; 2004 Nov; 108(11):682-9. PubMed ID: 15584353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to T-cell Ig and mucin domain-containing proteins (Tim)-1 and -3 suppress the induction and progression of murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Akiba H; Okumura K; Yagita H; Ueno H
    Biochem Biophys Res Commun; 2007 Feb; 353(1):211-6. PubMed ID: 17174273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of thymus-derived CD4+CD25+ T cells abrogates the suppressive effects of alpha-galactosylceramide treatment on experimental allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Ueno H; Taguchi O
    Allergol Int; 2008 Sep; 57(3):241-6. PubMed ID: 18493168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1726-31. PubMed ID: 16289109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periostin deletion suppresses late-phase response in mouse experimental allergic conjunctivitis.
    Asada Y; Okano M; Ishida W; Iwamoto S; Fukuda K; Hirakata T; Tada N; Fukushima A; Ebihara N; Kudo A; Matsuda A
    Allergol Int; 2019 Apr; 68(2):233-239. PubMed ID: 30420208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymus-derived CD4+ CD25+ T cells suppress the development of murine allergic conjunctivitis.
    Sumi T; Fukushima A; Fukuda K; Kumagai N; Nishida T; Takeuchi M; Taguchi O; Ueno H
    Int Arch Allergy Immunol; 2007; 143(4):276-81. PubMed ID: 17356295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Sumi T; Fukuda K; Kumagai N; Nishida T; Takeuchi M; Taguchi O; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):705-14. PubMed ID: 17024440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the interaction between IFN-gamma and IFN-gammaR in the effector phase of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Tsuru E; Ueno H
    Immunol Lett; 2006 Nov; 107(2):119-24. PubMed ID: 16987553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of Epithelial Cell-Derived Type 2-Initiating Cytokines in Experimental Allergic Conjunctivitis.
    Asada Y; Nakae S; Ishida W; Hori K; Sugita J; Sudo K; Fukuda K; Fukushima A; Suto H; Murakami A; Saito H; Ebihara N; Matsuda A
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5194-202. PubMed ID: 26244295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of T-cells in the development of allergic conjunctival diseases.
    Fukushima A
    Cornea; 2007 Oct; 26(9 Suppl 1):S36-40. PubMed ID: 17881914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin suppresses ovalbumin-induced allergic conjunctivitis.
    Chung SH; Choi SH; Choi JA; Chuck RS; Joo CK
    Mol Vis; 2012; 18():1966-72. PubMed ID: 22876123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.